DCGI gives nod to Hetero Labs and Cipla to manufacture and market remdesivir

The emergency approval is given to an unapproved therapy for compassionate use provided drug companies share the clinical data of the drug on patients where it is used.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2V190Z0
via IFTTT